Concepedia

Gregory S. Bisacchi

GS

Statistics

Publications

30

Citations

1.9K

H-Index

24

Active since

1976

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

AstraZeneca (United States)

Institute for Medical Research

Gregory S. Bisacchi is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1976–2023

30

Publications

30

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

Steven Innaimo, Maria Seifer, Gregory S. Bisacchi et al. · Antimicrobial Agents and Chemotherapy · 1997 · 273 citations · Full text

, , +16

A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV

Gregory S. Bisacchi, John I. Manchester · ACS Infectious Diseases · 2014 · 180 citations · Full text

, , +16

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

Gregory S. Bisacchi, Sam Chao, C. Bachard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 142 citations

, , +8

Structures, functions and adaptations of the human LINE-1 ORF2 protein

Eric T. Baldwin, Trevor van Eeuwen, David Hoyos et al. · Nature · 2023 · 123 citations · Full text

, , +13

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Gregory Yamanaka, T. P. Wilson, Steven Innaimo et al. · Antimicrobial Agents and Chemotherapy · 1999 · 106 citations · Full text

, , +16

1–5 of 30